⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT March 5, 2026

Legalon SIL - Pulver zur Herstellung einer Infusionslösung (Pulver zur Herstellung einer Infusionslösung)

📷 EU Safety Watch placeholder
Legalon SIL - Pulver zur Herstellung einer Infusionslösung (Pulver zur Herstellung einer Infusionslösung)
📷 EU Safety Watch placeholder
Parallel export is banned for this medicine. It is a powder used to make an infusion solution. Supply is delayed.
⚠️
Shortage ongoing
SILIBININ DINATRIUMDIHEMISUCCINAT is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? This is a powder medicine used to make a drip (infusion) for liver problems. It contains silibinin.

What's happening? There is a delay in getting new supplies of this medicine. Some packs are hard to find now.

Does this affect me? If you need this medicine for your liver, you may have trouble getting it right now in Austria.

What should I do? Ask your pharmacist or doctor for advice before you run out.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
SILIBININ DINATRIUMDIHEMISUCCINAT
Agency-published detail

🚫 Parallel export ban active · ATC: A05BA03 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Viatris Austria GmbH, Guglgasse 15, 1110 Wien, Österreich · Affected packs: 4 Stück Schachtel, Durchstechflasche [eingeschränkt verfügbar, since 2026-02-27, resupply 2026-06-01]

First published
March 5, 2026
Last refreshed by us
1 week ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Legalon SIL - Pulver zur Herstellung einer Infusionslösung (Pulver zur Herstellung einer Infusionslösung). Parallel export is banned for this medicine. It is a powder used to make an infusion solution. Supply is delayed.
▸ When was this alert issued?
This alert was issued on March 5, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.